Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA raises recall alert on listeria-tainted broccoli
Sorbet Recall Update As FDA Sets Highest Risk Level
A sorbet-filled mochi recalled due to an undeclared allergen has been given the U.S. Food and Drug Administration (FDA)'s highest risk level. The My Mochi Ice Cream Company of Vernon, California, recalled 1,
Walmart broccoli recall elevated to highest level by FDA over risk of ‘death’
Broccoli packages sold at Walmart stores in 20 states have received an elevated recall status over a Listeria contamination that has potentially fatal consequences. The U.S. Food and Drug Administration ( FDA) raised the recall on Braga Fresh’s ready-to-eat 12oz Marketside Broccoli Florets to Class 1,
FDA raises recall alert on listeria-tainted broccoli over serious 'death risk'
CDC officials exposure to listeria can cause of plethora of serious health problems, especially to children and elderly individuals who have weaker immune systems
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Novo Nordisk’s Ozempic Gets FDA Approval
FDA Approves Ozempic to Treat Kidney Disease
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.
US FDA Approves Novo Nordisk's Ozempic to Cut Risk of Diabetic Kidney Disease Progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
soapcentral
4h
Why did the FDA issue its highest-risk recall on Lay’s potato chips? Reasons explained
For many, Lay’s potato chips are a go-to snack. Recently, a serious recall has raised concerns for consumers, especially ...
11h
Popular Super Bowl snack recalled under FDA’s highest risk
Check your snacks before the Super Bowl. The Food and Drug Administration has given the highest risk classification to a ...
3d
on MSN
Food and Drug Administration wants to put nutrition labels front and center on food products
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
McKnight's Long-Term Care News
3h
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
8h
Did RFK Jr.’s Lawyer Ask the FDA to Revoke Approval for the Polio Vaccine?
Aaron Siri, a lawyer advising Robert F. Kennedy Jr. as he prepared to become health secretary, petitioned the Food and Drug ...
13h
FDA elevates Lay's potato chip recall in Oregon, Washington to highest risk level
Class I, according to the FDA, means exposure to or consumption of the product could cause "serious adverse health ...
11h
on MSN
FDA Upgrades Lay’s Classic Chips Recall to Deadliest Classification
More than 6,000 bags of Lay’s Classic Chips have been recalled by the FDA and classified at the highest risk level due to ...
The American Spectator
1h
Trump: Look at the Slow-Moving FDA
The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
United States
Ozempic
Novo Nordisk
Feedback